Variability in bioavailability of small molecular tyrosine kinase inhibitors

M Herbrink, B Nuijen, JHM Schellens… - Cancer treatment reviews, 2015 - Elsevier
Small molecular tyrosine kinase inhibitors (smTKIs) are in the centre of the very quickly
expanding area of personalized chemotherapy and oral applicability thereof. The number of …

Preparation and biophysical characterization of quercetin inclusion complexes with β-cyclodextrin derivatives to be formulated as possible nose-to-brain quercetin …

K Manta, P Papakyriakopoulou… - Molecular …, 2020 - ACS Publications
Quercetin (Que) is a flavonoid associated with high oxygen radical scavenging activity and
potential neuroprotective activity against Alzheimer's disease. Que's oral bioavailability is …

[HTML][HTML] Eco-directed sustainable prescribing: feasibility for reducing water contamination by drugs

CG Daughton - Science of the total environment, 2014 - Elsevier
Active pharmaceutical ingredients (APIs) from the purchase and use of medications are
recognized as ubiquitous contaminants of the environment. Ecological impacts can range …

Impact of gut microbiota-mediated bile acid metabolism on the solubilization capacity of bile salt micelles and drug solubility

EF Enright, SA Joyce, CGM Gahan… - Molecular …, 2017 - ACS Publications
In recent years, the gut microbiome has gained increasing appreciation as a determinant of
the health status of the human host. Bile salts that are secreted into the intestine may be …

Revising pharmacokinetics of oral drug absorption: I models based on biopharmaceutical/physiological and finite absorption time concepts

P Macheras, P Chryssafidis - Pharmaceutical research, 2020 - Springer
Purpose To demonstrate that oral drug absorption is terminated in finite time. To develop
models based on biopharmaceutical/physiological and finite absorption time concepts …

Differences in food effects for 2 weak bases with similar BCS drug-related properties: what is happening in the intestinal lumen?

R Cristofoletti, N Patel, JB Dressman - Journal of Pharmaceutical Sciences, 2016 - Elsevier
Ketoconazole and posaconazole are both Biopharmaceutics Classification System class 2
drugs (highly permeable, poorly soluble), are structurally similar, and are administered at the …

Model-Informed Drug Development: In Silico Assessment of Drug Bioperformance following Oral and Percutaneous Administration

J Djuris, S Cvijic, L Djekic - Pharmaceuticals, 2024 - mdpi.com
The pharmaceutical industry has faced significant changes in recent years, primarily
influenced by regulatory standards, market competition, and the need to accelerate drug …

Exploring the oxidation and iron binding profile of a cyclodextrin encapsulated quercetin complex unveiled a controlled complex dissociation through a chemical …

DA Diamantis, S Ramesova, CM Chatzigiannis… - … et Biophysica Acta (BBA …, 2018 - Elsevier
Background Flavonoids possess a rich polypharmacological profile and their biological role
is linked to their oxidation state protecting DNA from oxidative stress damage. However, their …

A non-binary biopharmaceutical classification of drugs: the ABΓ system

P Macheras, V Karalis - International journal of pharmaceutics, 2014 - Elsevier
The purpose of the present work is to develop a non-binary biopharmaceutical classification
system the so called ABΓ system. The original mathematical model used for the …

Plasma modification of microporous polymer membranes for application in biomimetic dissolution studies

MM Puppolo, JR Hughey, B Weber, T Dillon, D Storey… - AAPS Open, 2017 - Springer
Biorelevant dissolution is an indispensable tool utilized during formulation development and
optimization for the prediction of in vivo bioavailability of pharmaceutical agents. Within that …